These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26093250)

  • 21. Considerations of the chemical biology of microbial natural products provide an effective drug discovery strategy.
    Choi H; Oh DC
    Arch Pharm Res; 2015 Sep; 38(9):1591-605. PubMed ID: 26231248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 14-3-3: A Case Study in PPI Modulation.
    Ballone A; Centorrino F; Ottmann C
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products.
    Wolter M; de Vink P; Neves JF; Srdanović S; Higuchi Y; Kato N; Wilson A; Landrieu I; Brunsveld L; Ottmann C
    J Am Chem Soc; 2020 Jul; 142(27):11772-11783. PubMed ID: 32501683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein interaction networks as starting points to identify novel antimicrobial drug targets.
    Zoraghi R; Reiner NE
    Curr Opin Microbiol; 2013 Oct; 16(5):566-72. PubMed ID: 23938265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of α-helix-mediated protein-protein interactions using designed molecules.
    Azzarito V; Long K; Murphy NS; Wilson AJ
    Nat Chem; 2013 Mar; 5(3):161-73. PubMed ID: 23422557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-level bioinformatics resources support drug target discovery of protein-protein interactions.
    Liu JX; Zhang X; Huang YQ; Hao GF; Yang GF
    Drug Discov Today; 2024 May; 29(5):103979. PubMed ID: 38608830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization and inhibition of protein-protein interactions: the 14-3-3 case study.
    Milroy LG; Brunsveld L; Ottmann C
    ACS Chem Biol; 2013 Jan; 8(1):27-35. PubMed ID: 23210482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.
    Sugaya N; Ikeda K; Tashiro T; Takeda S; Otomo J; Ishida Y; Shiratori A; Toyoda A; Noguchi H; Takeda T; Kuhara S; Sakaki Y; Iwayanagi T
    BMC Pharmacol; 2007 Aug; 7():10. PubMed ID: 17705877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A time-resolved fluorescence resonance energy transfer screening assay for discovery of protein-protein interaction modulators.
    Tang C; Niu Q; Cicka D; Du Y; Mo X; Fu H
    STAR Protoc; 2021 Sep; 2(3):100804. PubMed ID: 34527960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.
    Scott DE; Bayly AR; Abell C; Skidmore J
    Nat Rev Drug Discov; 2016 Aug; 15(8):533-50. PubMed ID: 27050677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hot spots in protein-protein interfaces: towards drug discovery.
    Cukuroglu E; Engin HB; Gursoy A; Keskin O
    Prog Biophys Mol Biol; 2014; 116(2-3):165-73. PubMed ID: 24997383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting druggable binding sites at the protein-protein interface.
    Fuller JC; Burgoyne NJ; Jackson RM
    Drug Discov Today; 2009 Feb; 14(3-4):155-61. PubMed ID: 19041415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting protein-protein interactions and fragment-based drug discovery.
    Valkov E; Sharpe T; Marsh M; Greive S; Hyvönen M
    Top Curr Chem; 2012; 317():145-79. PubMed ID: 22006238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small-molecule modulators of 14-3-3 protein-protein interactions.
    Ottmann C
    Bioorg Med Chem; 2013 Jul; 21(14):4058-62. PubMed ID: 23266179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPLINTS: small-molecule protein ligand interface stabilizers.
    Fischer ES; Park E; Eck MJ; Thomä NH
    Curr Opin Struct Biol; 2016 Apr; 37():115-22. PubMed ID: 26829757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulating protein-protein interactions: the potential of peptides.
    Nevola L; Giralt E
    Chem Commun (Camb); 2015 Feb; 51(16):3302-15. PubMed ID: 25578807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motif mediated protein-protein interactions as drug targets.
    Corbi-Verge C; Kim PM
    Cell Commun Signal; 2016 Mar; 14():8. PubMed ID: 26936767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space.
    Zhang X; Betzi S; Morelli X; Roche P
    Future Med Chem; 2014 Jul; 6(11):1291-307. PubMed ID: 24773599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.